According to research conducted in the United States, 19 antibodies generated by the Pfizer vaccination dropped by more than 80% in senior nursing home residents and their carers six months after getting their second dose. Blood samples from 120 nursing home residents and 92 health care staff were analyzed in a study sponsored by Case Western Reserve University and Brown University in the United States.
Humoral immunity, also known as antibody-mediated immunity, was studied to assess the body’s defenses against the SARS-CoV-2 virus, which produces COVID-19. The yet-to-be-published study, which was released on the preprint platform medRxiv, revealed that people’s antibody levels had dropped by more than 80% after six months.
According to the researchers, the results were the same among elders (median age 76) and carers (median age 48) of all ages. The scientists previously discovered that within two weeks of getting the second dose of vaccination, seniors who had not once caught COVID-19 already had a much lower response in antibodies than the younger carers.
Read also: Mixing Covishield, Covaxin provides better immunity: ICMR
According to David Canaday, a Case Western Reserve University professor, 70% of these nursing home patients’ blood showed “inferior capacity to neutralize the coronavirus infection in laboratory trials” six months after vaccination.
According to Canaday, the findings back up the Centers for Disease Control and Prevention‘s (CDC) advice for booster injections, particularly for the elderly, owing to waning immunity. The boosters are much more significant than the Delta variant spreads, according to the study. Early in the pandemic, more significant COVID-19 mortality among nursing home patients in the United States prompted the researchers to make them a priority for immunization.
Read also: No sign of Covid-19 vaccine in breast milk: Study
According to them, the Pfizer vaccine was given to most nursing home inmates under emergency use authorizations because it was the first accessible vaccine on the market. The authors of the research have noted, “The definition of continuous immunity is crucial to promote public health policies in terms of the need to enhance the development of incident infections and outbreaks by the inadequate initial immunisation response of nursing homes.”
